Omega Healthcare Investors (BSP:O2HI34) Accounts Receivable: R$66 Mil (As of Mar. 2026)


BSP:O2HI34 Omega Healthcare Investors Inc BSP:O2HI34
49 GF Score
Price R$77.02
GF Value R$60.64
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Omega Healthcare Investors Accounts Receivable?

Omega Healthcare Investors BSP:O2HI34 -0.03% 49 Accounts Receivable is R$66 Mil as of Mar. 2026. GuruFocus rates BSP:O2HI34 with a GF Score™ of 49/100 and a GF Value™ of R$60.64 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Omega Healthcare Investors's accounts receivables for the quarter that ended in Mar. 2026 was R$66 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Omega Healthcare Investors's Days Sales Outstanding for the quarter that ended in Mar. 2026 was 3.58.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Omega Healthcare Investors's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was R$-87.93.


Omega Healthcare Investors Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Omega Healthcare Investors's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=66.28/1688.925*91
=3.58

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Omega Healthcare Investors's accounts receivable are only considered to be worth 75% of book value:

Omega Healthcare Investors's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(136.749+0.75 * 66.28+0.5 * 0-24995.041
-0-1378.193)/297.797
=-87.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Omega Healthcare Investors Accounts Receivable Related Terms


Omega Healthcare Investors Accounts Receivable Historical Data

* Premium members only.

The historical data trend for Omega Healthcare Investors's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omega Healthcare Investors Accounts Receivable Chart

Omega Healthcare Investors Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,433.43 945.90 1,094.70 1,586.80 1,559.95

Omega Healthcare Investors Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,583.92 1,478.43 1,481.50 1,559.95 66.28
BSP:O2HI34
49GF Score
Omega Healthcare Investors Inc BSP:O2HI34
Accounts Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omega Healthcare Investors Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Frequently Asked Questions Learn more about Accounts Receivable →
What does a Accounts Receivable of R$66 Mil mean?
Omega Healthcare Investors (BSP:O2HI34) has a Accounts Receivable of R$66 Mil as of Mar. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Omega Healthcare Investors and its competitors.
Is Omega Healthcare Investors' Accounts Receivable too high?
Omega Healthcare Investors' current Accounts Receivable is R$66 Mil. Overall, Omega Healthcare Investors has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Omega Healthcare Investors' Accounts Receivable compare to DOC and AHR?
Omega Healthcare Investors' Accounts Receivable of R$66 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a REITs company?
A good Accounts Receivable depends on the REITs industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Omega Healthcare Investors and its competitors. Omega Healthcare Investors's current Accounts Receivable is R$66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omega Healthcare Investors stock overvalued right now?
Based on GuruFocus' analysis, Omega Healthcare Investors (BSP:O2HI34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$60.64, compared to a current price of R$77.02 — trading 27% above its estimated fair value. The current Accounts Receivable is R$66 Mil. Omega Healthcare Investors' overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Omega Healthcare Investors (BSP:O2HI34), the current Accounts Receivable is R$66 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Omega Healthcare Investors (BSP:O2HI34) Overvalued in 2026?

Based on GuruFocus' analysis, Omega Healthcare Investors stock appears to be overvalued. The current stock price of R$77.02 is trading 27% above its estimated GF Value™ of R$60.64. GuruFocus considers Omega Healthcare Investors to be Modestly Overvalued.

Key valuation signals for BSP:O2HI34:

  • Accounts Receivable: R$66 Mil
  • GF Value™: R$60.64 vs. price of R$77.02 (27% above fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the BSP:O2HI34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Omega Healthcare Investors Business Description

Industry Real EstateREITs
Address 303 International Circle, Suite 200, Hunt Valley, MD, USA, 21030
Omega Healthcare Investors Inc is a real estate investment trust that invests in healthcare-related real estate properties located in the United States (U.S.), the United Kingdom (U.K.), and Canada. The company's objective is to provide attractive returns to investors while serving as the preferred capital partner to its third-party healthcare operating companies and affiliates, as well as other third-party healthcare operators, allowing them to focus on delivering a high level of care to their resident patients. Omega's investment portfolio mainly consists of skilled nursing facilities, assisted living facilities (ALFs), including care homes in the U.K., independent living facilities, rehabilitation and acute care facilities, and continuing care retirement communities.
49GF Score

Get the complete analysis for BSP:O2HI34

Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$77.02
Price
R$60.64
GF Value